First published 9/30/2026, 12:48:15 AM · Last updated 9/30/2026, 12:48:30 AM

Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for PJP prophylaxis after allogeneic hematopoietic cell transplantation: Association with bacterial infections and survival

Journal article comparing trimethoprim-sulfamethoxazole and aerosolized pentamidine for Pneumocystis jirovecii pneumonia prophylaxis after allogeneic hematopoietic cell transplantation, examining associations with bacterial infections and survival. The supplied excerpt contains no study methods, results, locations, or participant details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article addresses prophylaxis choices and clinical outcomes relevant to post‑transplant infection management.

Sources

Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for PJP prophylaxis after allogeneic hematopoietic cell transplantation: Association with bacterial infections and survival

Report an issue